Pandemic stress smoking is helping Big Tobacco
Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription.
So much for lockdowns making us more health-conscious. This month we saw Brits endure Arctic conditions for a pint. Now there’s data showing they’re smoking more too.
Market researcher Mintel found in a survey of 2,000 British adults last fall that more than half of cigarette users were stress smoking more than before the pandemic. Some 10% started smoking again after giving up. Overall, 30% of the smokers surveyed reported lighting up more regularly since the outbreak.
And the picture looks similar elsewhere: Many people in the U.S., as well as Canada, France, Israel and South Korea, have also said they are smoking more, according to Euromonitor International. After all, not only does working from home mean more smoke breaks, but add in the stress, isolation and boredom of lockdowns, and you have a recipe for good intentions going up in smoke.
But this recent uptick in smoking shouldn’t distract Big Tobacco. Manufacturers such as British American Tobacco, Philip Morris International and Altria Group still face serious head winds. This week the Biden administration threatened to cut nicotine levels in cigarettes so that they’ll be less addictive. And cigarette use overall remains on a long-term decline, with analysts at Jefferies predicting that in many markets there could be no smokers in 10 to 20 years.
Indeed, global cigarette volumes likely fell about 3% last year (excluding China and travel retail sales, which collapsed). That’s broadly in line with the downward trend of the last five years, though the mix was different: Developed markets, such as the U.S. and U.K., saw stronger sales, while those in some emerging markets fell.
So despite a work-from-home surge in smoking, the future of Big Tobacco still depends on its ability to develop less harmful alternatives. And there continues to be a great deal of debate over how much safer products like electronic cigarettes and devices that heat rather than burn tobacco actually are.
The most popular alternative is vaping. (Disclosure: Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent company of Bloomberg News, has campaigned against flavored e-cigarettes, and Bloomberg Philanthropies supports Protect Kids: Fight Flavored E-Cigarettes, an initiative to remove them from the market.) Mintel also found that 42% of British electronic cigarette users were vaping more regularly last year. Although the pandemic has had little effect on the U.S. vape market, alarms raised two years ago over vaping-related illnesses and a teen vaping epidemic had an impact: There were 9 million vapers in the U.S., last year, down from 12 million in 2019, according to ECigIntelligence, which tracks the market.
But U.S. electronic cigarette sales appear to be recovering this year, according to Nielsen data, and despite the maelstrom, they are still poised to grow much faster than cigarettes. The vaping crisis has also eased up, as it’s become clearer that the lung problems publicized two years ago were most likely not caused by legal e-cigarette cartridges, but by black-market versions containing THC, the psychoactive ingredient in marijuana, diluted with vitamin E acetate. Meanwhile, the percentage of U.S. high-school pupils vaping declined in 2020.
Devices that heat tobacco are another growing alternative. These are particularly popular in Japan, where they account for 28% of the total market, but are catching on in Europe and the U.S. Philip Morris on Tuesday upgraded its earnings outlook on the strength of its heated tobacco product. Philip Morris has spent more than $8 billion on its smoke-free products, which made up 28% of revenue in its first quarter this year. British American Tobacco has spent more than $7 billion developing a broad portfolio — including vaping, heat-not-burn, oral tobacco and most recently cannabidiol — that it hopes will generate as much in sales by 2025, approaching 20% of the total. It’s not clear which category, if any, will win out, so having options is wise.
Migrating from cigarettes to vapes, nicotine pouches and increasingly cannabis won’t be a straight line for Big Tobacco, as the U.S. vaping crisis demonstrated. And those heavy investments come with risks. (Remember Altria’s $12.8 billion stake in Juul Labs, which it later had to write down?) But the industry has little choice but to plow on if it wants to avoid its own stress smoking.
Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries.